M. Hershfield

Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.

R. Boulieu, C. Bory, G. Souillet, 1991, Advances in experimental medicine and biology.

Comparison of Red Cell Transfusion and Polyethylene Glycol-Modified Adenosine Deaminase Therapy in an Adenosine Deaminase-Deficient Child: Measurement of Erythrocyte Deoxyadenosine Triphosphate as a Useful Tool

M. Rolland, R. Boulieu, C. Bory, 1990, Pediatric Research.

The deficiency of adenosine deaminase type 2-results of therapeutic intervention

W. Flegel, I. Aksentijevich, D. Kastner, 2015, Pediatric Rheumatology.

Diagnosis of deficiency of adenosine deaminase type 2 in adulthood

A. Liston, L. Moens, I. Meyts, 2021, Scandinavian journal of rheumatology.

A case of severe combined immunodeficiency caused by adenosine deaminase deficiency with a new mutation.

E. Torun, Y. Camcıoğlu, O. Turel, 2017, Pediatrics and neonatology.